Researchers have found that Indian strains of HIV were most effectively neutralised by bNAbs targeting the virus’s V3 glycan while antibodies aimed at the V1/V2 apex of the viral spike protein were far less effective
Researchers have found that Indian strains of HIV were most effectively neutralised by bNAbs targeting the virus’s V3 glycan while antibodies aimed at the V1/V2 apex of the viral spike protein were far less effective